US Stocks Close Lower As Apple, Amazon Report Earnings: Greed Index Moves To 'Fear' Zone
Portfolio Pulse from Avi Kapoor
US stocks closed lower as Apple and Amazon reported earnings, with the CNN Money Fear and Greed index moving to the 'Fear' zone. The Dow Jones fell around 500 points, and the Nasdaq Composite ended July negatively. Moderna's stock dipped 21% due to lowered 2024 sales guidance, while Meta Platforms gained 4.8% after strong Q2 results. Investors await earnings from Exxon Mobil, Chevron, and Asbury Automotive Group.
August 02, 2024 | 6:38 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Meta Platforms' shares gained 4.8% after the company reported better-than-expected Q2 financial results and issued strong Q3 guidance.
Meta's stock price increase is due to the company's strong financial performance and positive future outlook, which are key drivers for investor sentiment.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Asbury Automotive Group's earnings results are awaited by investors, which could impact the stock price.
The anticipation of Asbury Automotive Group's earnings results introduces uncertainty, which could lead to stock price movements based on the financial performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
Chevron's upcoming earnings results are highly anticipated by investors, which could influence the stock price.
Similar to Exxon Mobil, the anticipation of Chevron's earnings results adds uncertainty, potentially affecting the stock price based on the reported performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
Investors are awaiting earnings results from Exxon Mobil, which could impact the stock price based on the company's performance.
The anticipation of Exxon Mobil's earnings results creates uncertainty, which could lead to volatility in the stock price depending on the outcome.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEGATIVE IMPACT
Moderna's stock dipped 21% as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines.
The significant drop in Moderna's stock price is directly tied to the company's announcement of lowered sales guidance, which is a critical factor for investors.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100